112 related articles for article (PubMed ID: 26020061)
21. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components.
Sutcliffe IC; Harrington DJ
FEMS Microbiol Rev; 2004 Nov; 28(5):645-59. PubMed ID: 15539077
[TBL] [Abstract][Full Text] [Related]
22. SInCRe-structural interactome computational resource for Mycobacterium tuberculosis.
Metri R; Hariharaputran S; Ramakrishnan G; Anand P; Raghavender US; Ochoa-Montaño B; Higueruelo AP; Sowdhamini R; Chandra NR; Blundell TL; Srinivasan N
Database (Oxford); 2015; 2015():bav060. PubMed ID: 26130660
[TBL] [Abstract][Full Text] [Related]
23. Database interrogation algorithms for identification of proteins in proteomic separations.
Palagi PM; Lisacek F; Appel RD
Methods Mol Biol; 2009; 519():515-31. PubMed ID: 19381607
[TBL] [Abstract][Full Text] [Related]
24. Detection of selective antibacterial peptides by the Polarity Profile method.
Polanco C; Buhse T; Samaniego JL; Castañón-González JA
Acta Biochim Pol; 2013; 60(2):183-9. PubMed ID: 23741718
[TBL] [Abstract][Full Text] [Related]
25. Domain analysis of fatty acid synthase protein (NP_217040) from Mycobacterium tuberculosis H37Rv--a bioinformatics study.
Ramesh KV; Wagle K; Deshmukh S
J Biomol Struct Dyn; 2007 Feb; 24(4):393-412. PubMed ID: 17206854
[TBL] [Abstract][Full Text] [Related]
26. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
27. Secretome profile analysis of hypervirulent Mycobacterium tuberculosis CPT31 reveals increased production of EsxB and proteins involved in adaptation to intracellular lifestyle.
Vargas-Romero F; Guitierrez-Najera N; Mendoza-Hernández G; Ortega-Bernal D; Hernández-Pando R; Castañón-Arreola M
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26733498
[TBL] [Abstract][Full Text] [Related]
28. Predict mycobacterial proteins subcellular locations by incorporating pseudo-average chemical shift into the general form of Chou's pseudo amino acid composition.
Fan GL; Li QZ
J Theor Biol; 2012 Jul; 304():88-95. PubMed ID: 22459701
[TBL] [Abstract][Full Text] [Related]
29. Identification of Mycobacterium tuberculosis H37Rv integral membrane proteins by one-dimensional gel electrophoresis and liquid chromatography electrospray ionization tandem mass spectrometry.
Xiong Y; Chalmers MJ; Gao FP; Cross TA; Marshall AG
J Proteome Res; 2005; 4(3):855-61. PubMed ID: 15952732
[TBL] [Abstract][Full Text] [Related]
30. Predicting the subcellular localization of mycobacterial proteins by incorporating the optimal tripeptides into the general form of pseudo amino acid composition.
Zhu PP; Li WC; Zhong ZJ; Deng EZ; Ding H; Chen W; Lin H
Mol Biosyst; 2015 Feb; 11(2):558-63. PubMed ID: 25437899
[TBL] [Abstract][Full Text] [Related]
31. Roles of PE_PGRS family in Mycobacterium tuberculosis pathogenesis and novel measures against tuberculosis.
Tian C; Jian-Ping X
Microb Pathog; 2010 Dec; 49(6):311-4. PubMed ID: 20638467
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the proteomes of isoniazid-resistant Mycobacterium tuberculosis strains and isoniazid-susceptible strains].
Jiang X; Gao F; Zhang WH; Hu ZY; Wang HH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):427-31. PubMed ID: 17673015
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterial proteomics: analysis of expressed proteomes and post-translational modifications to identify candidate virulence factors.
Calder B; Soares NC; de Kock E; Blackburn JM
Expert Rev Proteomics; 2015 Feb; 12(1):21-35. PubMed ID: 25603863
[TBL] [Abstract][Full Text] [Related]
34. Potential non homologous protein targets of mycobacterium tuberculosis H37Rv identified from protein-protein interaction network.
Melak T; Gakkhar S
J Theor Biol; 2014 Nov; 361():152-8. PubMed ID: 25106794
[TBL] [Abstract][Full Text] [Related]
35. Increased virulence of Mycobacterium tuberculosis H37Rv overexpressing LipY in a murine model.
Singh VK; Srivastava M; Dasgupta A; Singh MP; Srivastava R; Srivastava BS
Tuberculosis (Edinb); 2014 May; 94(3):252-61. PubMed ID: 24631199
[TBL] [Abstract][Full Text] [Related]
36. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
37. ESAT-6 proteins: protective antigens and virulence factors?
Brodin P; Rosenkrands I; Andersen P; Cole ST; Brosch R
Trends Microbiol; 2004 Nov; 12(11):500-8. PubMed ID: 15488391
[TBL] [Abstract][Full Text] [Related]
38. Polar profile of antiviral peptides from AVPpred Database.
Polanco C; Samaniego JL; Castañón-González JA; Buhse T
Cell Biochem Biophys; 2014 Nov; 70(2):1469-77. PubMed ID: 24993579
[TBL] [Abstract][Full Text] [Related]
39. Immunoproteomic identification of secretory and subcellular protein antigens and functional evaluation of the secretome fraction of Mycobacterium immunogenum, a newly recognized species of the Mycobacterium chelonae-Mycobacterium abscessus group.
Gupta MK; Subramanian V; Yadav JS
J Proteome Res; 2009 May; 8(5):2319-30. PubMed ID: 19209886
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometry-based proteomics combined with bioinformatic tools for bacterial classification.
Dworzanski JP; Deshpande SV; Chen R; Jabbour RE; Snyder AP; Wick CH; Li L
J Proteome Res; 2006 Jan; 5(1):76-87. PubMed ID: 16396497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
